Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elena Kvan

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
European Journal of Clinical Pharmacology|March 23, 2004
The problem of underdosing of angiotensin-converting enzyme inhibitors is markedly overrated: results from a study of patients discharged from hospital after an acute myocardial infarctionElena Kvan, Aasmund Reikvam,
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|September 3, 2005
[Long-cycle oral contraceptives--a progress?]Elena Kvan, Sigrid Narum
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|March 12, 2010
[Sex differences and cardiovascular drugs]Maja-Lisa Løchen, Elena Kvan
Cardiovascular Drugs and Therapy|March 26, 2003
Use of cardiovascular drugs after acute myocardial infarction: a marked shift towards evidence-based drug therapyAsmund Reikvam, Elena Kvan, Ivar Aursnes
Blood Pressure|April 18, 2003
Antihypertensive therapy at the onset of an acute myocardial infarction predicts in-hospital mortalityKnud Landmark, Ivar Aursnes, Elena Kvan, et al.
Scandinavian Cardiovascular Journal : SCJ|July 26, 2003
Angiotensin-converting enzyme (ACE) inhibitor therapy after myocardial infarction in relation to left ventricular functionAasmund Reikvam, Elena Kvan, Knud Landmark, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|March 9, 2011
RAS inhibitors and size of infarctKnud Landmark, Ivar Aursnes, Elena Kvan, et al.
Pharmacoepidemiology and Drug Safety|November 30, 2005
Treatment with statins after acute myocardial infarction in patients >or=80 years: underuse despite general acceptance of drug therapy for secondary preventionElena Kvan, Kjell I Pettersen, Knud Landmark, et al.
International Journal of Cardiology|December 23, 2006
High mortality in diabetic patients with acute myocardial infarction: cardiovascular co-morbidities contribute most to the high riskElena Kvan, Kjell I Pettersen, Leiv Sandvik, et al.
BMC Cardiovascular Disorders|October 14, 2008
Health-related quality of life after myocardial infarction is associated with level of left ventricular ejection fractionKjell I Pettersen, Elena Kvan, Arnfinn Rollag, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
European Journal of Clinical Pharmacology|March 23, 2004
The problem of underdosing of angiotensin-converting enzyme inhibitors is markedly overrated: results from a study of patients discharged from hospital after an acute myocardial infarctionElena Kvan, Aasmund Reikvam,
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|September 3, 2005
[Long-cycle oral contraceptives--a progress?]Elena Kvan, Sigrid Narum
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|March 12, 2010
[Sex differences and cardiovascular drugs]Maja-Lisa Løchen, Elena Kvan
Cardiovascular Drugs and Therapy|March 26, 2003
Use of cardiovascular drugs after acute myocardial infarction: a marked shift towards evidence-based drug therapyAsmund Reikvam, Elena Kvan, Ivar Aursnes
Blood Pressure|April 18, 2003
Antihypertensive therapy at the onset of an acute myocardial infarction predicts in-hospital mortalityKnud Landmark, Ivar Aursnes, Elena Kvan, et al.
Scandinavian Cardiovascular Journal : SCJ|July 26, 2003
Angiotensin-converting enzyme (ACE) inhibitor therapy after myocardial infarction in relation to left ventricular functionAasmund Reikvam, Elena Kvan, Knud Landmark, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|March 9, 2011
RAS inhibitors and size of infarctKnud Landmark, Ivar Aursnes, Elena Kvan, et al.
Pharmacoepidemiology and Drug Safety|November 30, 2005
Treatment with statins after acute myocardial infarction in patients >or=80 years: underuse despite general acceptance of drug therapy for secondary preventionElena Kvan, Kjell I Pettersen, Knud Landmark, et al.
International Journal of Cardiology|December 23, 2006
High mortality in diabetic patients with acute myocardial infarction: cardiovascular co-morbidities contribute most to the high riskElena Kvan, Kjell I Pettersen, Leiv Sandvik, et al.
BMC Cardiovascular Disorders|October 14, 2008
Health-related quality of life after myocardial infarction is associated with level of left ventricular ejection fractionKjell I Pettersen, Elena Kvan, Arnfinn Rollag, et al.
Pageof 2